United front against Italy's hemp flower ban
L‘Italy’s recent ban on hemp flowers sparked a rare display of unity among regional agricultural leaders, legal experts, and industry stakeholders.
This measure, adopted as part of the government's new «security decree,» reclassifies the hemp flowers and non-psychoactive cannabinoids such as the CBD, the CBG and the CBN in the category of controlled substances, regardless of the THC content of products that may contain it.
The unanimous view is that this is an ideological decision that undermines regional autonomy, violates European Union law, and threatens a rapidly growing economic sector.
Agricultural leaders condemn the ban
Regional agricultural advisors from all over Italy, who are members of the Italian Confederation of Agriculture (CIA)), have publicly condemned the government’s approach. In a joint statement, they described the ban as «an entire, rapidly growing supply chain» that is being «wiped out» by «ideological» regulations, according to Massimo Pica, a spokesperson for the CIA.
This is the strongest political response to date against the Prime Minister's government Giorgia Meloni, who enacted the decree without in-depth parliamentary debate. Mr. Pica emphasized the broader implications of this measure: «The ban affects not only farmers, but also downstream industries such as construction, bioplastics, and textiles that depend on the hemp »as a raw material."
A major blow to Italy's sustainable economy
At the heart of the controversy lies the’Article 18 something new safety decree, which makes no distinction between the industrial hemp and cannabis with a high THC content. This approach is in direct contradiction to the European Union regulations, which allows for the free movement of hemp-based products containing less than 0.3 % of THC.
The decree criminalizes the cultivation, processing, and sale of hemp flowers, even though this crop has been legally cultivated in Italy since 2016.
«The government’s actions do not take scientific evidence into account and fail to recognize the proven safety and economic potential of industrial hemp,» Mr. Pica added.
Industry experts warn that this legal conflation of hemp and psychotropic substances will harm Italy’s competitiveness in the fields of bio-based materials, the’climate-smart agriculture and the’green innovation – sectors in which other European countries are making significant progress.
Legal Setbacks and Constitutional Doubts
Regulatory pressure on the Italian hemp industry intensified in April when the Regional Administrative Court of Lazio rejected an appeal seeking to lift the’national ban on orally administered CBD products. The court invoked the «precautionary principle,» citing potential liver toxicity and psychiatric effects, despite scientific studies and EU classifications that recognize that CBD is not addictive and is not a psychotropic substance.
This decision is a setback for the hemp advocates and legal experts who had hoped the courts would enhance regulatory clarity and scientific rigor. The decision heightened concerns about the government’s growing reliance on executive powers.
«Both the security decree and the ban on CBD were enacted without a full parliamentary debate,» the report notes, raising constitutional questions. Under the’Article 77 of the Italian Constitution, such emergency decrees must be justified by the urgency of the situation and ratified by Parliament within 60 days, a procedure that is currently under close scrutiny.
The combined effects of bans on hemp flowers and CBD could impact more than 3,000 companies and jeopardize 30,000 jobs in a sector with an estimated value of nearly 2 billion euros. In response, a coalition of advocacy groups—including Canapa Sativa Italia, Resilienza Italia Onlus, and Imprenditori Canapa Italia– has launched coordinated legal and political campaigns to overturn the bans in Italy and at the European level.
«Hemp industry professionals, who follow the rules every day and ensure a transparent and safe market, should not fear the government, but should receive its support,» said Mattia Cusani from Canapa Sativa Italia during a hearing before the Committee on Petitions of the European Parliament in March.
In Brussels, the European Commission has already requested clarification from the Italian government, thereby triggering a 90-day review period. Hemp advocates hope the EU will intervene to protect the internal market and prevent what they consider a dangerous precedent.
-
Business4 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in Quebec3 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in New Zealand3 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
Cannabis in France3 weeks ago
Dr. Pascal Douek, a tireless advocate for medical cannabis in France, has died
-
Cannabis in France3 weeks ago
Medical cannabis: The Greens introduce two amendments to accelerate its widespread adoption
-
Cannabis in Spain4 weeks ago
Spain: Medical Cannabis Is Coming to About 50 Hospitals
-
Business4 weeks ago
British patients now have access to THCV-rich cannabis flowers
-
Cannabis in Canada3 weeks ago
A Canadian study reveals the pleasant psychotropic effects of high-dose CBD


You must be logged in to post a comment Login